Loading…
Remedium Lifecare (BSE 539561)₹0.27000.00%Trading & Distributors
In the Sep 2025 quarter (consolidated), Remedium Lifecare reported sales of ₹111 Cr and net profit of ₹8.63 Cr. For the year to Mar 2025, sales were ₹405 Cr and net profit ₹2.01 Cr.
Company filings, consolidated accounts; latest reported quarter Sep 2025
| Mar 2025 | Jun 2025 | Sep 2025 | |
|---|---|---|---|
| Sales | 264 | 113 | 111 |
| Expenses | 264 | 111 | 103 |
| Operating Profit | −0.45 | 1.86 | 7.35 |
| OPM % | −0.2% | 1.7% | 6.7% |
| Other Income | 0.65 | 3.47 | 3.24 |
| Interest | 1.58 | −0.35 | 0.18 |
| Depreciation | 0.02 | 0.00 | 0.00 |
| Profit before tax | −1.41 | 5.72 | 10.47 |
| Tax % | 45.7% | 18.6% | 17.3% |
| Net Profit | −2.06 | 4.66 | 8.63 |
| EPS (Rs) | −0.03 | 0.06 | 0.11 |
| Mar 2025 | |
|---|---|
| Sales | 405 |
| Expenses | 403 |
| Operating Profit | 0.99 |
| OPM % | 0.3% |
| Other Income | 10.97 |
| Interest | 7.99 |
| Depreciation | 0.00 |
| Profit before tax | 4.01 |
| Tax % | 51.0% |
| Net Profit | 2.01 |
| EPS (Rs) | 0.03 |
| Dividend payout % | 0.0% |
| Mar 2025 | |
|---|---|
| Equity Capital | 39.92 |
| Reserves | 3.99 |
| Borrowings | 1,138 |
| Other Liabilities | 532 |
| Total Liabilities | 1,715 |
| Fixed Assets | 0.00 |
| CWIP | 0.00 |
| Investments | 0.00 |
| Other Assets | 1,715 |
| Inventories | 268 |
| Trade receivables | 771 |
| Cash & equivalents | 0.99 |
| Total Assets | 1,715 |
| Mar 2025 | |
|---|---|
| Cash from operating activity | −1,136 |
| Cash from investing activity | 0.00 |
| Cash from financing activity | 1,133 |
| Net cash flow | 1.01 |
| Free cash flow | −1,139 |
| CFO / OP % | −90,063.9% |
| Mar 2025 | |
|---|---|
| Debtor days | 696 |
| Inventory days | 248 |
| Days payable | 459 |
| Cash conversion cycle | 483 |
| Working capital days | 37 |
For the Sep 2025 quarter, Remedium Lifecare reported sales of ₹111 Cr and net profit of ₹8.63 Cr. The operating margin was 6.7%.
Remedium Lifecare's sales for the year to Mar 2025 were ₹405 Cr.
Net profit for the year to Mar 2025 was ₹2.01 Cr. Earnings per share over the same trailing period were ₹0.03.
Remedium Lifecare reported borrowings of ₹1,138 Cr at Mar 2025, against cash and equivalents of ₹0.99 Cr.
Cash from operations was −₹1,136 Cr in the year to Mar 2025; after capital spending, free cash flow was −₹1,139 Cr.